Bortezomib 1.6 mg/m2

DRUG2 trials

Sponsors

University of Massachusetts, Worcester, Hackensack Meridian Health

Conditions

Lung CancerMultiple Myeloma

Phase 1

Phase I/II Study to Evaluate the Efficacy and Safety of a Combination Chemotherapy

TerminatedNCT00424840

University of Massachusetts, WorcesterLung Cancer

Start: 2006-06-30End: 2014-03-31Updated: 2019-02-01

Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma

CompletedNCT00784823

Hackensack Meridian HealthMultiple Myeloma

Start: 2007-01-31End: 2013-12-31Updated: 2022-08-11

Related Papers

Melphalan + bortezomib (MelVel) and Mel + Vel + thalidomide (MelVelThal) as a conditioning regimen for autologous peripheral blood stem cell transplantation (ASCT) in patients (pts) with advanced multiple myeloma (MM): An updated analysis of 2 phase I/II studies.

Journal of Clinical Oncology2016-05-20